Comparative Study of the Combination of Different Modes of Administration of Local Anesthetics in Labor Analgesia

July 20, 2020 updated by: Marian Daras

The investigators have design an observational study to know the anesthetic consumption in terms of rescue analgesia (Patient Controlled Epidural Analgesia (PCEA) and manual boluses) of the combination of different modes of administration of local anesthetic in the epidural space during labor analgesia offered by the new version of the CADD® infusion pump.

Also in this pump the anesthetic can be administered across a system of standard flow (40-250ml/h) or of high flow (40-500ml/h), what according to studies can influence the diffusion epidural of the anesthetic and therefore the level of sensitive blockade.

Study Overview

Detailed Description

The study is designed with healthy patients, first-time mothers, in childbearing dynamics, term pregnancy and nullipary. The epidural technique was performed with dose test of 3ml of bupivacaína 0,25 % with vasoconstrictor and a manual bolus of 0,1ml/Kg of ropivacaína 0,2% with fentanilo 5ug/ml.

As soon as the informed consent about the epidural anesthesia was signed, the patient was informed of the possibility of taking part in the study and there is offered him the sheet of information of the patient. So in one group they were administered Programed Intermittent Epidural Boluses (PIEB) and in other group continuous Epidural Infusion (IC) plus PIEB according to the usual clinical practice of each anesthesiologist. In both cases the perfusion was of ropivacaína 0,1 % more fentanilo 2ug/ml, so that in the first group it was administered PIEB of 10ml every hour and in the second group a continuous infusion to 3ml/h plus PIEB of 7ml every hour. Also if during the period of dilatation an AVE (Analogical Visual Escale) greater than or equal to 4 appeared (inadequate analgesia) the patient could administer a 5ml PCEA bolus of the same solution (interval of closing of 20min and maximum dose for hour of 15ml), as it is done in according to the usual clinical practice. And if after two boluses of PCEA the analgesia was still ineffective a clinical bolus of 4ml of lidocaína to 1 % was administered by the anesthesiologist.

In addition, in the group that was administered only PIEB, the standard infusion system was compared with the high-flow infusion system.

In all patients it was evaluated and noted on the epidural record sheet the intensity of the pain as the analogical visual scale (AVE), the grade of motor blockade as the modified scale of Bromage and the sensitive level in different periods of time. Also registered the total doses of anesthetic, the way of the childbearing finishes, the Apgar of the newborn, the grade of maternal satisfaction and the side effects. Also through the software of the pump it was verified if the patient had been administered rescue analgesia (PCEA or clinical boluses).

Study Type

Observational

Enrollment (Actual)

151

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Castellón
      • Villarreal, Castellón, Spain, 12540
        • Hospital Universitario de La Plana

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 43 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

The study will be realized in women in work of labor who come our hospital and who after being valued by the team of obstetrics are in favorable active period for the achievement of the technique epidural previous informed consent.

Description

Inclusion Criteria:

  • Pregnant women in work of established labor and contractions of moderate intensity
  • Age between 18 and 45 years
  • ASA I and II
  • Nulliparity
  • Pregnancy to term (> 36semanas)
  • The only fetus of cephalic presentation
  • Cervical dilation between 2-5cm

Exclusion Criteria:

  • Maternal systemic illness (Diabetes Mellitus, arterial Hypertension, Preeclampsia. . )
  • Major or equal weight to 100 Kg
  • Less height of 150cm
  • Duration of the equal or major childbearing to 24h
  • Administration of opioides parenterales in 2-4h before to performing of the epidural
  • Contraindication for neuroaxial analgesia
  • Precedents of allergy or hypersensitivity to anesthetic local

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
IC+PIEB+PCEA high flow
Continuous Epidural Infusion to 3ml/h more Programed Intermittent Epidural Boluses of 7ml every hour with PCEA of 5 ml (interval of closing of 20min and maximum dose for hour of 15ml) administered with system of infusion of high flow as clinical practice routine

Ropivacaina 0,1 % is used with fentanilo 2ug/ml Also if during the dilation period a greater or equal AVE appears to 4 (inadequate analgesia) the patient can be administered a bolus of PCEA of the same solution.

If the patient is administered PCEA, the programed intermittent epidural bolus is delayed automatically 20 minutes with regard to the time in which it would have to be administrated.

If after two bolus of PCEA the analgesia keeps on being ineffective a clinical bolus is administered by the anaesthetist of 4ml of lidocaína to 1 %.

This intervention is included in the clinical practice routine

PIEB+PCEA high flow
Programed Intermittent Epidural Boluses of 10ml every hour with PCEA of 5 ml (interval of closing of 20min and maximum dose for hour of 15ml) administered with system of infusion of high flow as clinical practice routine

Ropivacaina 0,1 % is used with fentanilo 2ug/ml Also if during the dilation period a greater or equal AVE appears to 4 (inadequate analgesia) the patient can be administered a bolus of PCEA of the same solution.

If the patient is administered PCEA, the programed intermittent epidural bolus is delayed automatically 20 minutes with regard to the time in which it would have to be administrated.

If after two bolus of PCEA the analgesia keeps on being ineffective a clinical bolus is administered by the anaesthetist of 4ml of lidocaína to 1 %.

In the group of pure boluses 10ml / h of perfusion will be administered through the high flow and standard flow infusion system, and the maximum sensory level achieved will be compared.

This intervention is included in the clinical practice routine

PIEB+PCEA standar flow
Programed Intermittent Epidural Boluses of 10ml every hour with PCEA of 5 ml (interval of closing of 20min and maximum dose for hour of 15ml) administered with system of infusion of standar flow as clinical practice routine

Ropivacaina 0,1 % is used with fentanilo 2ug/ml Also if during the dilation period a greater or equal AVE appears to 4 (inadequate analgesia) the patient can be administered a bolus of PCEA of the same solution.

If the patient is administered PCEA, the programed intermittent epidural bolus is delayed automatically 20 minutes with regard to the time in which it would have to be administrated.

If after two bolus of PCEA the analgesia keeps on being ineffective a clinical bolus is administered by the anaesthetist of 4ml of lidocaína to 1 %.

In the group of pure boluses 10ml / h of perfusion will be administered through the high flow and standard flow infusion system, and the maximum sensory level achieved will be compared.

This intervention is included in the clinical practice routine

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
anesthetic consumption in milliliters
Time Frame: at the end of labour
The anesthetic consumption in terms of analgesia of rescue of the combination of different ways of administration of anesthetic in the space epidural. The quantity of extra analgesic is already by means of boluses of PCEA or by means of clinical boluses measured in milliliters
at the end of labour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
analgesic effectiveness with AVE
Time Frame: Baseline (just after epidural administration)
Measurement by means of the evaluation of the intensity of the pain that will be evaluated according to the analogical visual scale (AVE) with values between 0 and 10
Baseline (just after epidural administration)
analgesic effectiveness with AVE
Time Frame: 15 minutes after epidural administration
Measurement by means of the evaluation of the intensity of the pain that will be evaluated according to the analogical visual scale (AVE) with values between 0 and 10
15 minutes after epidural administration
analgesic effectiveness with AVE
Time Frame: 30 minutes after epidural administration
Measurement by means of the evaluation of the intensity of the pain that will be evaluated according to the analogical visual scale (AVE) with values between 0 and 10
30 minutes after epidural administration
analgesic effectiveness with AVE
Time Frame: every 2 hours until the end of labor
Measurement by means of the evaluation of the intensity of the pain that will be evaluated according to the analogical visual scale (AVE) with values between 0 and 10
every 2 hours until the end of labor
Motor blockade from zero to four
Time Frame: Baseline (just after epidural administration)

The grade of motive blockade registers according to the modified scale of Bromage (from 0 to 3):

0 = it can raise the low extremities of the bed

  1. = it can bend knees and ankles
  2. = it can bend ankles but not the knees
  3. = it can bend neither ankles nor knees
Baseline (just after epidural administration)
Motor blockade from zero to four
Time Frame: 15 minutes after epidural administration

The grade of motive blockade registers according to the modified scale of Bromage (from 0 to 3):

0 = it can raise the low extremities of the bed

  1. = it can bend knees and ankles
  2. = it can bend ankles but not the knees
  3. = it can bend neither ankles nor knees
15 minutes after epidural administration
Motor blockade from zero to four
Time Frame: 30 minutes after epidural administration

The grade of motive blockade registers according to the modified scale of Bromage (from 0 to 3):

0 = it can raise the low extremities of the bed

  1. = it can bend knees and ankles
  2. = it can bend ankles but not the knees
  3. = it can bend neither ankles nor knees
30 minutes after epidural administration
Motor blockade from zero to four
Time Frame: every 2 hours until the end of labor

The grade of motive blockade registers according to the modified scale of Bromage (from 0 to 3):

0 = it can raise the low extremities of the bed

  1. = it can bend knees and ankles
  2. = it can bend ankles but not the knees
  3. = it can bend neither ankles nor knees
every 2 hours until the end of labor
Sensitive blockade from T12 to T4
Time Frame: Baseline (just after epidural administration)
The sensory level reached will be valued according to the loss of sensibility to the cold by means of a cotton with alcohol, noting down the dermatoma where it does not exist or diminishes the sensibility (T4: nipples level, T10: level of the bellybutton, T12: groin region). For statistical analysis of this variable a numerical value was given to each dermatome so that the highest value represents a higher sensory level and therefore more dermatomes with sensitive block (T12 = 0 and T4 = 8).
Baseline (just after epidural administration)
Sensitive blockade from T12 to T4
Time Frame: 15 minutes after epidural administration
The sensory level reached will be valued according to the loss of sensibility to the cold by means of a cotton with alcohol, noting down the dermatoma where it does not exist or diminishes the sensibility (T4: nipples level, T10: level of the bellybutton, T12: groin region ). For statistical analysis of this variable a numerical value was given to each dermatome so that the highest value represents a higher sensory level and therefore more dermatomes with sensitive block (T12 = 0 and T4 = 8).
15 minutes after epidural administration
Sensitive blockade from T12 to T4
Time Frame: 30 minutes after epidural administration
The sensory level reached will be valued according to the loss of sensibility to the cold by means of a cotton with alcohol, noting down the dermatoma where it does not exist or diminishes the sensibility (T4: nipples level, T10: level of the bellybutton, T12: groin region). For statistical analysis of this variable a numerical value was given to each dermatome so that the highest value represents a higher sensory level and therefore more dermatomes with sensitive block (T12 = 0 and T4 = 8).
30 minutes after epidural administration
Sensitive blockade from T12 to T4
Time Frame: every 2 hours until the end of labor
The sensory level reached will be valued according to the loss of sensibility to the cold by means of a cotton with alcohol, noting down the dermatoma where it does not exist or diminishes the sensibility (T4: nipples level, T10: level of the bellybutton, T12: groin region). For statistical analysis of this variable a numerical value was given to each dermatome so that the highest value represents a higher sensory level and therefore more dermatomes with sensitive block (T12 = 0 and T4 = 8).
every 2 hours until the end of labor
Blood pressure
Time Frame: Baseline (just after epidural administration)
The patient will be evaluated and there will register the blood pressure in mm of mercury
Baseline (just after epidural administration)
Blood pressure
Time Frame: 15 minutes after epidural administration
The patient will be evaluated and there will register the blood pressure in mm of mercury
15 minutes after epidural administration
Blood pressure
Time Frame: 30 minutes after epidural administration
The patient will be evaluated and there will register the blood pressure in mm of mercury
30 minutes after epidural administration
Blood pressure
Time Frame: every 2 hours until the end of labor
The patient will be evaluated and there will register the blood pressure in mm of mercury
every 2 hours until the end of labor
Maternal heart rate
Time Frame: Baseline (just after epidural administration)
The patient will be evaluated and there will register the maternal heart rate in beats per minute
Baseline (just after epidural administration)
Maternal heart rate
Time Frame: 15 minutes after epidural administration
The patient will be evaluated and there will register the maternal heart rate in beats per minute
15 minutes after epidural administration
Maternal heart rate
Time Frame: 30 minutes after epidural administration
The patient will be evaluated and there will register the maternal heart rate in beats per minute
30 minutes after epidural administration
Maternal heart rate
Time Frame: every 2 hours until the end of labor
The patient will be evaluated and there will register the maternal heart rate in beats per minute
every 2 hours until the end of labor
maternal satisfaction
Time Frame: at the end of labor

On having finished the childbearing, from 0 to 100 will value the grade of maternal satisfaction as an evaluation scale:

  • 0 = very unsatisfied with the analgesia provided by the treatment
  • 100 = extremely satisfied with the analgesia provided by the treatment
at the end of labor
adverse effects
Time Frame: at the end of labor
There will be noted down also the appearance of adverse effects as the sickness and vomiting, urinal retention, pruritus and fever.
at the end of labor

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight in kilograms
Time Frame: Just before epidural administration
The weight in kilograms will be noted on the epidural record sheet
Just before epidural administration
Size in centimeters
Time Frame: Just before epidural administration
The height in centimeters will be noted on the epidural record sheet
Just before epidural administration
ASA from one to five
Time Frame: Just before epidural administration
The ASA classification will be noted on the epidural record sheet
Just before epidural administration
Gestational week in number
Time Frame: Just before epidural administration
The Gestational week in number will be noted on the epidural record sheet
Just before epidural administration
Cervical dilatation at the time of performing the epidural technique in centimeters
Time Frame: Just before epidural administration
The dilatation in centimeters will be noted on the epidural record sheet
Just before epidural administration
Administration of parenteral opioids and the time of administration
Time Frame: Just before epidural administration
In the epidural record sheet if opioids have been administered it will be recorded as YES and if they have not been administered it will be recorded as NO. If it has been administered, the time of its admnistracion will be indicated numerically
Just before epidural administration

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 2, 2015

Primary Completion (Actual)

February 28, 2019

Study Completion (Actual)

February 28, 2019

Study Registration Dates

First Submitted

January 30, 2019

First Submitted That Met QC Criteria

February 11, 2019

First Posted (Actual)

February 15, 2019

Study Record Updates

Last Update Posted (Actual)

July 22, 2020

Last Update Submitted That Met QC Criteria

July 20, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor Epidural Analgesia

Clinical Trials on IC+PIEB+PCEA high flow

3
Subscribe